Raffael Frei

Newly appointed to the Board of SpinChip in the spring of 2023, Frei has more than 25 years of experience in the field of In Vitro Diagnostics during which time he has contributed to successfully launching new IVD platforms into the European market. After graduating from the University of Johannesburg as a Biomedical Technologist, Frei has gathered vast experience working in several hospital laboratories and Diagnostic companies in a number of positions including Application Specialist, Product and Sales Manager. Frei is currently a Member of the Executive Board and Business Unit Head of the hospital division at Axon Lab AG.